UBS Group
ASPX

UBS Group’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

UBS Group’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-300
Closed -$30K – 9272
2015
Q1 		$30K Buy
+300
New +$20K ﹤0.01% 6566

UBS Group's ASPX Position: Q2 2015 in Review

UBS Group sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 300 shares — an estimated $30K sold.

UBS Group first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $30K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • UBS Group reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • UBS Group sold 300 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $30K.
  • UBS Group first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • UBS Group's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $30K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on UBS Group's 13F filing for Q2 2015, filed 14 Aug 2015.